Publication | Closed Access
A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells
27
Citations
33
References
2015
Year
GliomaMedicineStem CellsNovel Drug ConjugateMesenchymal SubtypesCancer BiologyTumor TargetingAnti-cancer AgentHigh-grade GliomasCancer TreatmentRadiation OncologyOncologyCell BiologyHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1